Previous proteomic profiling of urine samples from five individuals with BLCA and five healthy participants demonstrated substantial elevation of PRDX1 levels among cancer patients (Figure 9A), suggesting its value as a non-invasive diagnostic indicator for initial screening. Here, PRDX1 is linked to cancer.